BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 11040070)

  • 1. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
    Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
    J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.
    Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M
    Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain.
    Giudice GJ; Emery DJ; Zelickson BD; Anhalt GJ; Liu Z; Diaz LA
    J Immunol; 1993 Nov; 151(10):5742-50. PubMed ID: 8228259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
    Mariotti F; Grosso F; Terracina M; Ruffelli M; Cordiali-Fei P; Sera F; Zambruno G; Mastrogiacomo A; Di Zenzo G
    Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype.
    Metz BJ; Ruggeri SY; Hsu S; Reed JA; Ghohestani AS; Uitto J; Ghohestani RF
    Int J Dermatol; 2004 Jun; 43(6):443-6. PubMed ID: 15186228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an ELISA for the detection of autoantibodies to BP230.
    Kromminga A; Sitaru C; Hagel C; Herzog S; Zillikens D
    Clin Immunol; 2004 Apr; 111(1):146-52. PubMed ID: 15093564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease.
    Georgi M; Scheckenbach C; Kromminga A; Partscht K; Messer G; Bröcker EB; Zillikens D
    Arch Dermatol Res; 2001 Mar; 293(3):109-14. PubMed ID: 11357223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
    Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC
    J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
    Schmidt E; Skrobek C; Kromminga A; Hashimoto T; Messer G; Bröcker EB; Yancey KB; Zillikens D
    Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.
    Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D
    Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.
    Shinojima Y; Ochiai T; Kawamura A; Arakawa H; Fukuda K; Hashimoto T
    Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule.
    Lin MS; Fu CL; Olague-Marchan M; Hacker MK; Zillikens D; Giudice GJ; Fairley JA
    Clin Immunol; 2002 Mar; 102(3):310-9. PubMed ID: 11890718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients.
    Mulyowa GK; Jaeger G; Kabakyenga J; Bröcker EB; Zillikens D; Schmidt E
    Int J Dermatol; 2006 Sep; 45(9):1047-52. PubMed ID: 16961507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
    Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
    J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
    Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
    J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain.
    Hofmann S; Thoma-Uszynski S; Hunziker T; Bernard P; Koebnick C; Stauber A; Schuler G; Borradori L; Hertl M
    J Invest Dermatol; 2002 Nov; 119(5):1065-73. PubMed ID: 12445194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.